Inovio Pharmaceuticals Stock News

There are several reasons why the U.S. government might be choosing not to back the development of INO-4800 with big money, but two stand out.

Inovio stock will live and die by its coronavirus vaccine results. However, INO stock continues to trade well, with a solid chart setup.

So, what's the verdict? Stay on the sidelines with INO stock for now, but consider shares if they continue falling back to lower prices.

With the pandemic rearing its ugly head again, these nine companies should give you significant growth potential.

The

So far Wednesday, August 5, NASDAQ is up 1.65% and the S&P is up 0.59%. Here are this morning’s most

Robinhood investors like two fast-growing biotechs and one big pharma company that each have promising COVID-19 vaccine candidates.

Inclusion in a government program to fight the spread of the coronavirus is a major catalyst event for INO stock. The post It’s Warp Speed Ahead Now for Inovio appeared first on InvestorPlace.

MRNA, PFE/BNTX, and AZN are leading the three vaccines in clinical phase 3 trials.

Inovio Pharmaceuticals (NASDAQ: INO) is enjoying its best stock performance in seven years thanks to investors' interest in its novel coronavirus vaccine program. VBI Vaccines (NASDAQ: VBIV) appears

Inovio Pharmaceuticals: A Focus On The HPV Pipeline Candidates

There are no signs the coronavirus pandemic is slowing down in the U.S., with more than 1,100 Americans dying every day from COVID-19 in recent days. Beyond the staggering fatalities, one estimate by

Which of these cutting-edge biotech companies is leading the coronavirus vaccine race?

The shares have soared as vaccine candidates progress through human trials. Can the gains continue?

After a market crushing performance during the first half of the year, one of 2020’s best performers has been struggling of late. The last month has seen shares of Inovio Pharmaceuticals (INO) de